The FDA and the Cardiovascular Community
- PMID: 38925726
- DOI: 10.1016/j.jacc.2024.05.013
The FDA and the Cardiovascular Community
Keywords: Food and Drug Administration; artificial intelligence; cardiovascular disease; digital health; heart failure; randomized controlled trials.
Conflict of interest statement
Funding Support and Author Disclosures Drs Warraich and Califf are employees of the U.S. Food and Drug Administration. Dr Warraich previously served on the medical advisory board for GoodRx. Dr Califf has been an employee of and held equity in Verily Life Sciences and Google Health (Alphabet); and has served on boards of directors for Cytokinetics, Centessa, Clinetic, Keystone Symposia, the Critical Path Institute (C-Path), the Clinical Research Forum, and One Fifteen.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources